MedPath

Betadine

Betadine® 5%Sterile OphthalmicPrep Solution(povidone-iodine ophthalmic solution)(0.5% available iodine)

Approved
Approval ID

72287bb4-3f70-4e12-aaf3-cfff48e044f8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 25, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

povidone-iodine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-006
Application NumberNDA018634
Product Classification
M
Marketing Category
C73594
G
Generic Name
povidone-iodine
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateFebruary 17, 2009
FDA Product Classification

INGREDIENTS (7)

POVIDONE-IODINEActive
Quantity: 5 mg in 1 mL
Code: 85H0HZU99M
Classification: ACTIM
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QP
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
NONOXYNOL-9Inactive
Code: 48Q180SH9T
Classification: IACT
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Betadine - FDA Drug Approval Details